Research study Program year 2025 Source: CMS Open Payments

Hepatic Impairment Study

Research payments

$3,452,522

40 payments

Through program year 2025, $3,452,522 in research payments was reported against Hepatic Impairment Study, across 40 payments.

Paid by (largest first)
Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH; H. Lundbeck A S
ClinicalTrials.gov
No trial number was reported for this study

By program year

4 rows
Year Kind Amount Payments
2025 Research $28,100 2
2024 Research $691,186 11
2023 Research $2,419,924 15
2022 Research $313,312 12

Breakdown

Who paid Research payments · program years 2022–2025
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $3,204,244 23 payments
  2. Boehringer Ingelheim International GmbH $220,178 15 payments
  3. H. Lundbeck A S $28,100 2 payments
Who received the money Research payments · program years 2022–2025
  1. Covenant Research Organisation paid for research $1,763,783 4 payments
  2. American Research Corporation Organisation paid for research $608,140 4 payments
  3. Im Super Holdings LLC Organisation paid for research $289,119 2 payments
  4. The Institute For Liver Health LLC Organisation paid for research $229,471 6 payments
  5. Diagnostics Research Group Organisation paid for research $143,018 5 payments
  6. American Research Corporation INC Organisation paid for research $121,281 1 payment
  7. Covenant Research and Clinics LLC Organisation paid for research $114,927 1 payment
  8. The Institute for Liver Health LLC Arizona Clinical Trials Organisation paid for research $78,784 2 payments
  9. Covenant Metabolic Specialists-Sarasota Organisation paid for research $37,796 5 payments
  10. IM Super Holdings LLC dba IMA Evaluations LLC Organisation paid for research $23,541 1 payment

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

4 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record